Leading Edge Financial Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Sell
1,045
-1
-0.1% -$233 0.05% 63
2026
Q1
$256K Buy
1,046
+44
+4% +$10.2K 0.05% 63
2025
Q4
$207K Buy
+1,002
New +$198K 0.05% 65
2023
Q4
Sell
-1,454
Closed -$226K 64
2023
Q3
$226K Buy
1,454
+7
+0.5% +$1.16K 0.15% 60
2023
Q2
$239K Sell
1,447
-116
-7% -$18.7K 0.16% 57
2023
Q1
$242K Buy
1,563
+10
+0.6% +$1.61K 0.18% 59
2022
Q4
$274K Buy
+1,553
New +$268K 0.24% 55

Other funds holding JNJ

Leading Edge Financial Planning's JNJ Position: Q2 2026 in Review

Leading Edge Financial Planning reduced its Johnson & Johnson (JNJ) stake by 0.1% in Q2 2026, selling an estimated $233 and leaving 1,045 shares worth $265K. The position accounts for 0.05% of the portfolio, ranked #63.

Leading Edge Financial Planning first reported a position in JNJ in Q4 2022 and has held it in 7 quarters since. The position peaked at $274K in Q4 2022. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Leading Edge Financial Planning held 1,045 shares of Johnson & Johnson worth $265K as of Q2 2026.
  • Leading Edge Financial Planning sold 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.05% of Leading Edge Financial Planning's portfolio in Q2 2026, its #63 holding.
  • Leading Edge Financial Planning first reported a position in Johnson & Johnson in Q4 2022 and has held it in 7 quarters since.
  • Leading Edge Financial Planning's Johnson & Johnson position peaked at $274K in Q4 2022.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Leading Edge Financial Planning's 13F filing for Q2 2026, filed 6 Aug 2026.